ALFA Filings
Every announcement, straight from the exchange
Every Aarti Pharmalabs other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Aarti Pharmalabs Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Aarti Pharmalabs Limited has reconstituted its Nomination and Remuneration Committee effective October 01, 2026. Smt. Jeenal Savla will serve as the Chairperson of the committee.
Aarti Pharmalabs has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26 as per SEBI regulations.
Aarti Pharmalabs Ltd submitted its quarterly compliance certificate under Regulation 74(5) for the period ended March 31, 2026. The registrar, MUFG Intime India, confirmed no dematerialisation requests were received during the quarter. This is a routine regulatory disclosure with no material financial impact.
Aarti Pharmalabs Limited launched the 'Saksham Niveshak' campaign from April 1 to July 9, 2026. Initiated by the IEPFA, the drive encourages shareholders to update KYC details and claim unpaid dividends before they are transferred to the Investor Education and Protection Fund.